Abstract
The British comparative thromboplastin (BCT) was used to monitor the effectiveness of oral anticoagulants in preventing deep vein thrombosis (DVT) in patients undergoing major gynaecological surgery. All patients were screened for DVT with the use of the 125I-fibrinogen scan.
One hundred and forty-five patients aged 40 years or more were randomised into three groups. Group 1 received oral anticoagulant (nicoumalone) treatment, stabilised over five days before surgery and continuing into the second postoperative week. The other patients served as two contrast groups and were managed on a double-blind basis. Group 2 received a subcutaneous low-dose regimen of heparin calcium. Group 3 received subcutaneous saline. Eleven of 48 patients in the saline group, three of 49 patients in the heparin group, and three of 48 patients in the oral anticoagulant group developed DVT as judged by 125I-fibrinogen scanning. The incidences in groups 1 and 2 were significantly lower than in the saline group. The falls in haemoglobin concentration and incidence of haemorrhage were similar in all three groups.
The study showed that oral anticoagulant prophylaxis stabilised preoperatively and low-dose heparin were equally effective in preventing deep vein thrombosis in a moderate-risk group. Immediate preoperative prothrombin ratios of 2·0-2·5 and postoperative ratios of 2·0-4·0 with the BCT gave adequate protection without increased haemorrhagic risk.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baertschi U., Schaer A., Bader P., Huber L., Morf P. Thromboseprophylaxe nach gynäkologischen Operationen: Eine Vergleichsstudie von Low-Dose-Heparin und oralen Antikoagulantien. Geburtshilfe Frauenheilkd. 1975 Oct;35(10):754–760. [PubMed] [Google Scholar]
- Ballard R. M., Bradley-Watson P. J., Johnstone F. D., Kenney A., McCarthy T. G. Low doses of subcutaneous heparin in the prevention of deep vein thrombosis after gynaecological surgery. J Obstet Gynaecol Br Commonw. 1973 May;80(5):469–472. doi: 10.1111/j.1471-0528.1973.tb15963.x. [DOI] [PubMed] [Google Scholar]
- Kakkar V. V., Nicolaides A. N., Renney J. T., Friend J. R., Clarke M. B. 125-I-labelled fibrinogen test adapted for routine screening for deep-vein thrombosis. Lancet. 1970 Mar 14;1(7646):540–542. doi: 10.1016/s0140-6736(70)90769-5. [DOI] [PubMed] [Google Scholar]
- Morris G. K., Mitchell J. R. Prevention and diagnosis of venous thrombosis in patients with hip fractures. A survey of current practice. Lancet. 1976 Oct 23;2(7991):867–869. doi: 10.1016/s0140-6736(76)90535-3. [DOI] [PubMed] [Google Scholar]
- Poller L., Thomson J. M. Measuring partial thromboplastin-time. An international collaborative study. Lancet. 1976 Oct 16;2(7990):842–846. doi: 10.1016/s0140-6736(76)91224-1. [DOI] [PubMed] [Google Scholar]
- van Vroonhoven T. J., van Zijl J., Muller H. Low-dose subcutaneous heparin versus oral anticoagulants in the prevention of postoperative deep-venous thrombosis. A controlled clinical trial. Lancet. 1974 Mar 9;1(7854):375–378. doi: 10.1016/s0140-6736(74)93147-x. [DOI] [PubMed] [Google Scholar]